nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.146	0.277	CbGbCtD
Moclobemide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.122	0.232	CbGbCtD
Moclobemide—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.116	0.222	CbGbCtD
Moclobemide—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.057	0.108	CbGbCtD
Moclobemide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0523	0.0995	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.032	0.061	CbGbCtD
Moclobemide—Procainamide—BCHE—peripheral nervous system neoplasm	0.00195	0.713	CrCbGaD
Moclobemide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000828	0.00175	CcSEcCtD
Moclobemide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000828	0.00175	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000824	0.00175	CcSEcCtD
Moclobemide—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000824	0.00175	CcSEcCtD
Moclobemide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000822	0.00174	CcSEcCtD
Moclobemide—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000822	0.00174	CcSEcCtD
Moclobemide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000821	0.00174	CcSEcCtD
Moclobemide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000821	0.00174	CcSEcCtD
Moclobemide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000819	0.00174	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000818	0.00173	CcSEcCtD
Moclobemide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00081	0.00172	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000801	0.0017	CcSEcCtD
Moclobemide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.0008	0.0017	CcSEcCtD
Moclobemide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000795	0.00169	CcSEcCtD
Moclobemide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000794	0.00168	CcSEcCtD
Moclobemide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000794	0.00168	CcSEcCtD
Moclobemide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000792	0.00168	CcSEcCtD
Moclobemide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00079	0.00167	CcSEcCtD
Moclobemide—Haloperidol—ABCB1—peripheral nervous system neoplasm	0.000786	0.288	CrCbGaD
Moclobemide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00166	CcSEcCtD
Moclobemide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000784	0.00166	CcSEcCtD
Moclobemide—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000783	0.00166	CcSEcCtD
Moclobemide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000782	0.00166	CcSEcCtD
Moclobemide—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000782	0.00166	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000782	0.00166	CcSEcCtD
Moclobemide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00078	0.00165	CcSEcCtD
Moclobemide—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000779	0.00165	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000776	0.00164	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.00164	CcSEcCtD
Moclobemide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000774	0.00164	CcSEcCtD
Moclobemide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000774	0.00164	CcSEcCtD
Moclobemide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000772	0.00164	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000772	0.00164	CcSEcCtD
Moclobemide—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000771	0.00163	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.00163	CcSEcCtD
Moclobemide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000767	0.00163	CcSEcCtD
Moclobemide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000767	0.00163	CcSEcCtD
Moclobemide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000766	0.00162	CcSEcCtD
Moclobemide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00162	CcSEcCtD
Moclobemide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000761	0.00161	CcSEcCtD
Moclobemide—Malaise—Etoposide—peripheral nervous system neoplasm	0.000758	0.00161	CcSEcCtD
Moclobemide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000758	0.00161	CcSEcCtD
Moclobemide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000752	0.00159	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00075	0.00159	CcSEcCtD
Moclobemide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000744	0.00158	CcSEcCtD
Moclobemide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000739	0.00157	CcSEcCtD
Moclobemide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000738	0.00156	CcSEcCtD
Moclobemide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000738	0.00156	CcSEcCtD
Moclobemide—Rash—Topotecan—peripheral nervous system neoplasm	0.000738	0.00156	CcSEcCtD
Moclobemide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000737	0.00156	CcSEcCtD
Moclobemide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000737	0.00156	CcSEcCtD
Moclobemide—Headache—Topotecan—peripheral nervous system neoplasm	0.000733	0.00155	CcSEcCtD
Moclobemide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000732	0.00155	CcSEcCtD
Moclobemide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000732	0.00155	CcSEcCtD
Moclobemide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000731	0.00155	CcSEcCtD
Moclobemide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000731	0.00155	CcSEcCtD
Moclobemide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000731	0.00155	CcSEcCtD
Moclobemide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000731	0.00155	CcSEcCtD
Moclobemide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000728	0.00154	CcSEcCtD
Moclobemide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000727	0.00154	CcSEcCtD
Moclobemide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000727	0.00154	CcSEcCtD
Moclobemide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000726	0.00154	CcSEcCtD
Moclobemide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.00154	CcSEcCtD
Moclobemide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000725	0.00154	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.00153	CcSEcCtD
Moclobemide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000724	0.00153	CcSEcCtD
Moclobemide—Rash—Melphalan—peripheral nervous system neoplasm	0.000722	0.00153	CcSEcCtD
Moclobemide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000721	0.00153	CcSEcCtD
Moclobemide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000719	0.00152	CcSEcCtD
Moclobemide—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000718	0.00152	CcSEcCtD
Moclobemide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000716	0.00152	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000713	0.00151	CcSEcCtD
Moclobemide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000707	0.0015	CcSEcCtD
Moclobemide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0007	0.00148	CcSEcCtD
Moclobemide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000699	0.00148	CcSEcCtD
Moclobemide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000695	0.00147	CcSEcCtD
Moclobemide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000695	0.00147	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000693	0.00147	CcSEcCtD
Moclobemide—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000693	0.00147	CcSEcCtD
Moclobemide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000692	0.00147	CcSEcCtD
Moclobemide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000689	0.00146	CcSEcCtD
Moclobemide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000689	0.00146	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000683	0.00145	CcSEcCtD
Moclobemide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000681	0.00144	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00068	0.00144	CcSEcCtD
Moclobemide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00068	0.00144	CcSEcCtD
Moclobemide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000673	0.00143	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00067	0.00142	CcSEcCtD
Moclobemide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00067	0.00142	CcSEcCtD
Moclobemide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00142	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.00141	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000664	0.00141	CcSEcCtD
Moclobemide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000659	0.0014	CcSEcCtD
Moclobemide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000651	0.00138	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000649	0.00138	CcSEcCtD
Moclobemide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000641	0.00136	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.00136	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000633	0.00134	CcSEcCtD
Moclobemide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000631	0.00134	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00063	0.00134	CcSEcCtD
Moclobemide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000622	0.00132	CcSEcCtD
Moclobemide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000617	0.00131	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000616	0.00131	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000612	0.0013	CcSEcCtD
Moclobemide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00061	0.00129	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00129	CcSEcCtD
Moclobemide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000608	0.00129	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000603	0.00128	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000603	0.00128	CcSEcCtD
Moclobemide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.00127	CcSEcCtD
Moclobemide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000598	0.00127	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000597	0.00126	CcSEcCtD
Moclobemide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000592	0.00125	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000588	0.00125	CcSEcCtD
Moclobemide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000587	0.00124	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000586	0.00124	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.00124	CcSEcCtD
Moclobemide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.00123	CcSEcCtD
Moclobemide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00058	0.00123	CcSEcCtD
Moclobemide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000578	0.00123	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000566	0.0012	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000563	0.00119	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000561	0.00119	CcSEcCtD
Moclobemide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00056	0.00119	CcSEcCtD
Moclobemide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00118	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.00118	CcSEcCtD
Moclobemide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.00117	CcSEcCtD
Moclobemide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000554	0.00117	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000551	0.00117	CcSEcCtD
Moclobemide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000551	0.00117	CcSEcCtD
Moclobemide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000545	0.00116	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.00115	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000543	0.00115	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.00115	CcSEcCtD
Moclobemide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000539	0.00114	CcSEcCtD
Moclobemide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000538	0.00114	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000535	0.00113	CcSEcCtD
Moclobemide—Rash—Vincristine—peripheral nervous system neoplasm	0.000534	0.00113	CcSEcCtD
Moclobemide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000534	0.00113	CcSEcCtD
Moclobemide—Headache—Vincristine—peripheral nervous system neoplasm	0.000531	0.00112	CcSEcCtD
Moclobemide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.00111	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000522	0.00111	CcSEcCtD
Moclobemide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000513	0.00109	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00108	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000505	0.00107	CcSEcCtD
Moclobemide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000503	0.00107	CcSEcCtD
Moclobemide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000503	0.00107	CcSEcCtD
Moclobemide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000493	0.00104	CcSEcCtD
Moclobemide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000486	0.00103	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.00102	CcSEcCtD
Moclobemide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000476	0.00101	CcSEcCtD
Moclobemide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000472	0.001	CcSEcCtD
Moclobemide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000472	0.001	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00047	0.000995	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.00099	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000985	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000984	CcSEcCtD
Moclobemide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000463	0.00098	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000978	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000458	0.00097	CcSEcCtD
Moclobemide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000454	0.000962	CcSEcCtD
Moclobemide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000445	0.000943	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000941	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000927	CcSEcCtD
Moclobemide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000436	0.000925	CcSEcCtD
Moclobemide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000918	CcSEcCtD
Moclobemide—Rash—Etoposide—peripheral nervous system neoplasm	0.000433	0.000917	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000432	0.000916	CcSEcCtD
Moclobemide—Headache—Etoposide—peripheral nervous system neoplasm	0.00043	0.000911	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000911	CcSEcCtD
Moclobemide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000907	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000905	CcSEcCtD
Moclobemide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000901	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000898	CcSEcCtD
Moclobemide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000896	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000883	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000878	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000871	CcSEcCtD
Moclobemide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000408	0.000864	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000862	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000858	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000851	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000851	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000849	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000848	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000397	0.00084	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000834	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000832	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000829	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000822	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000817	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000812	CcSEcCtD
Moclobemide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000802	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000798	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000796	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000788	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000787	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000787	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000784	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000778	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.00077	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000762	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000761	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000743	CcSEcCtD
Moclobemide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000742	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000737	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000736	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000732	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000729	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000727	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000725	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000718	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000709	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000705	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000703	CcSEcCtD
Moclobemide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000697	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000687	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000682	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000677	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000673	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000672	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000671	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000667	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000664	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000656	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.00065	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000648	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000645	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000645	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000622	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000617	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000599	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000596	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000585	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000577	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000558	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000541	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000539	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000534	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000518	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000516	CcSEcCtD
Moclobemide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000514	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000514	CcSEcCtD
Moclobemide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000511	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000499	CcSEcCtD
Moclobemide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000484	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00048	CcSEcCtD
Moclobemide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000476	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000475	CcSEcCtD
Moclobemide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000473	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000448	CcSEcCtD
